CiteAb Names Cell Signaling Technology, “Antibody Company of the Year” and “Researchers’ Choice”
Cell Signaling Technology (CST), a leading provider of antibodies, kits and services, was honored with the 2016 CiteAb Award for “Researchers’ Choice” and for a second year in a row with the award for “Antibody Company of the Year.” Now in its second year, the CiteAb Antibody Awards aim to celebrate the very best suppliers, reagents and individuals in the research antibody sector, recognizing the efforts that are made to progress science.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160211005303/en/
Andrew Chalmers, Ph.D., founder of CiteAb, said: "The level of competition in the awards this year was very strong, so Cell Signaling Technology has done extremely well to have won in two categories. They received some glowing nominations for the researchers' choice award. At CiteAb we're looking forward to seeing the company develop and grow, and we wish the team at Cell Signaling many congratulations for their awards."
“As a company of scientists, we are humbled and honored to have our efforts recognized by the research community with these two awards. We know customers have a choice when it comes to their antibody supplier and we aim to stand apart through our rigorous development and validation processes and full-service technical support. These awards reinforce to us that the community at large values these efforts,” said Michael J. Comb, Ph.D., Cell Signaling Technology President and CEO.
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work.
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing the world’s highest quality, innovative, research and diagnostic products to accelerate biological understanding and enable personalized medicine. Our employees operate worldwide from our U.S. headquarters in Massachusetts, and our offices in the Netherlands, China, and Japan.
Cell Signaling Technology® , and CST™ are trademarks of Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc.
Rebecca J. Reppucci, MBA, 978-867-2382
Director of Marketing Communications
Katrina Kelly, 07403 668718
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ZEPHYRTEL26.9.2018 12:03 | pressemeddelelse
ZephyrTel Welcomes Vasona to Its Portfolio of Software Solutions Serving the Global Telecommunications Sector
IL-HALLSTAR26.9.2018 12:02 | pressemeddelelse
Hallstar Names Scott Hinkle as New Chief Financial Officer and Head of Global Shared Services
BOEHRINGER-INGELHEIM26.9.2018 10:02 | pressemeddelelse
Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC
SOFTATHOME26.9.2018 09:02 | pressemeddelelse
SoftAtHome Invests in Quality of Experience for Fixed-Mobile Convergence by Acquiring V3D, Leader in Telecom Data Analytics
EASY-VISUAL26.9.2018 09:02 | pressemeddelelse
Easy Visual Launches App For Targeted Advertising Reach Through Smartphones
CA-TELEFLEX26.9.2018 08:07 | pressemeddelelse
NeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift® System Treatment for Enlarged Prostate
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum